Anonymous
Guest
Anonymous
Guest
Up late? Get some rest. I think you're 100% off base.
You must really have your head in the sand. Have you talked to anyone in R&D in the Greater Boston area at all in the last 2 years? Have you read the news? Vertex, Millennium, Ariad, Aveo, Shire, Genzyme and Parexel - all had layoffs in the hundreds at minimum for 2013. Sitiris was closed down by parent company GSK. Smaller once up-and-coming companies like Immunogen, Infinity and Merrimack have had disappointing failures and look to be sputtering now. Genzyme will have more coming if they don't get the Dec 27th MS drug approval that has already received a scathing letter from a review committee. I'm probably even missing a few
Name me a sizable CRO based in MA besides Parexel ... you can't because they're all in the south taking advantage of cheap labor. Even Parexel is downsizing and shifting more overseas and down to their RTP offices.
Working from home has been great for work-life flexibility, but its opened all us in the northeast to wage competition from those in the south and midwest.
Have you heard of risk-based monitoring? How this tool is increasingly automating the high paying job of a CRA?
Oh and btw, the Boston Business Journal now has an article on its website on this very topic. The bubble is bursting.
Please wake-up.